Amdocs Limited
DOX · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $5 | $5 |
| % Growth | -9.4% | 2.4% | 6.8% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $3 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 36.6% | 35.1% | 35.3% | 35.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 18.2% | 12.6% | 13.4% | 14.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $0 | $1 | $1 |
| % Margin | 12.5% | 9.9% | 11.1% | 12% |
| EPS | 5.08 | 4.27 | 4.52 | 4.47 |
| % Growth | 19% | -5.5% | 1.1% | – |
| EPS Diluted | 5.05 | 4.25 | 4.49 | 4.44 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 20.5% | 16.4% | 17.5% | 19.4% |